<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0567439" disease_type="Disease or Syndrome" abbrv="">Genetic syndromes</z:e> that include <z:hpo ids='HP_0004322'>short stature</z:hpo> are recognized by their effect on children's growth rates, by their effect on the growth rate and pubertal development in adolescence, and by the presence of stigmata associated with certain syndromes </plain></SENT>
<SENT sid="1" pm="."><plain>The effects of Down, <z:e sem="disease" ids="C0265202" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Seckel</z:e>, Turner, Russell-Silver, Prader-Willi, and Noonan syndromes on growth and the growth-inhibiting features of <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>, <z:hpo ids='HP_0004912'>hypophosphatemic rickets</z:hpo>, and Laron <z:hpo ids='HP_0003510'>dwarfism</z:hpo> are reviewed </plain></SENT>
<SENT sid="2" pm="."><plain>The terminology used by professionals in discussing genetic alterations should minimize the effects of labeling and stigmatization and should emphasize the <z:mpath ids='MPATH_458'>normal</z:mpath> aspects of a child's life </plain></SENT>
</text></document>